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Abstract
Background: Acute flaccid paralysis surveillance (AFP) is an essential strategy of the WHO’s Polio Eradication
Initiative. This is the first study conducted to estimate the incidence, etiology, distribution, and surveillance
performance of AFP in Iraq.
Methods: Surveillance data about the AFP cases under the age of 15 years reported from Iraq during January 1997
to December 2011 were depended in the current study.
Results: A total of 4974 cases of AFP were reported from Iraq during the study period, with an annual incidence of
2.5/100,000 population. Guillain-Barré syndrome represented more than half of the reported cases (N = 2611, 52.5%),
followed by traumatic neuritis (N = 715, 14.4%), and other CNS infections (N = 292, 5.9%). Poliomyelitis accounted for
166 (3.3%) of cases, the last reported case being in January 2000. Surveillance performance showed that all, but
two, indicators were below the required WHO recommended levels.
Conclusions: AFP surveillance remains the gold standard method for poliomyelitis detection. It witnessed dramatic
changes over the last two decades. This has raised people’s and clinicians’ awareness to the importance of
promptness in notifying suspected cases and timely transportation of stool specimens to the National Poliovirus
Laboratory in Baghdad, or alternatively having more than one laboratory for poliovirus detection in the country, all
of which are very useful measures to increase the surveillance performance in the country.
Background
Poliomyelitis, or polio, is a highly contagious viral infec-
tion caused by poliovirus. Like most other Enterovirus
RNA viruses, poliovirus is transmitted by the feco-oral
route. The vast majority of infections are subclinical
(>90%), while the remainder present with a self-limited
illness of fever, myalgia, malaise, sore throat and headache
(abortive polio) or aseptic meningitis (i.e. non-paralytic
polio). The paralytic disease is by far the least common
presentation, accounting for 1 per 1000 cases among
infants and 1 per 100 cases among adolescents [1,2].
In 1988, the World Health Organization (WHO)
adopted the Global Polio Eradication Initiative (GPEI),
aiming to eradicate polio by the year 2000 [3]. Although
polio outbreaks continue to occur, polio cases have
witnessed a dramatic decrease by >99.9% since 1988 [4].
Along with attaining high routine vaccination coverage
rate, conducting National Immunization Days (NIDs), and
adopting “mopping-up” immunization; acute flaccid
paralysis (AFP) surveillance is an essential strategy of the
GPEI. It aims to identify high risk areas or groups,
monitor progress of polio status, indicate the need for
supplementary strategies if widespread outbreaks occur or
“mopping-up” immunization if restricted to limited foci, as
well as to certify a country polio-free. The latter requires
that “there are no reports of new cases of poliomyelitis
caused by wild poliovirus for three successive years”. It also
requires evidence that a country can detect a case of
paralytic polio should it occur [5].
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Iraq is a Middle Eastern country located in western Asia
covering an area of 435,052 km2 with 18 governorates
(provinces). It is bordered to the north by Turkey, to the
east by Iran, to the west by Syria and Jordan, and to the
south by Saudi Arabia and Kuwait. The population of Iraq
grew from about 22,046,000 in 1997 to about 33,330,000
in 2009 [6]. Immunization against polio was mandated by
the Iraqi Ministry of Health in 1985, according to
which each child should receive a first dose of OPV
within 2 weeks from birth. Subsequent doses should
be administrated at 2, 4 and 6 months. National
immunization days (NIDs) have been at least biannually
launched in Iraq since 1995. National reporting started in
Iraq since 1997. Virologic classification was introduced in
2000. Iraq has achieved and maintained these certification
standards since 1997 [7].
Many studies have been conducted on the causes of
AFP and its surveillance system performance, including
recent studies from different countries all around the
world [8-12]. However, unfortunately, no studies have
been carried out with the aim to estimate the incidence,
etiology, distribution, and surveillance performance of
AFP in Iraq.
Methods
Study design and population
The surveillance database of AFP cases under the age of
15 reported from Iraq during January 1997 to December
2011 was depended in the current study. The study was
approved by the Ethical Committee of the Faculty of
Medical Sciences/University of Duhok, Duhok, Iraq and
the Institutional Review Board (IRB) of the University of
Nebraska Medical Center, Omaha, Nebraska, USA.
AFP surveillance organization in Iraq
AFP information is routinely included in the weekly and
monthly reporting system from the Preventive Health
Department (PHD) in the Directorate General of Health
(DGoH) of every Iraqi province, even if there has been
no reported case (routine surveillance “zero-reporting”).
Notifications are done via mailing the standard commu-
nicable notification forms designed by the Ministry of
Health (MOH) to the Communicable Disease Control
Unit (CDCU) of the regional PHD. Active surveillance
for the suspected cases of AFP is ideally done within
48 hours via a designed investigator from the CDCU
visiting the reporting sources (hospitals, rehabilitation
centers, or private clinics). Case investigation is done
using a WHO-standardized form.
According to the WHO recommendations, two stool
specimens are collected from each suspected case with
an interval of 24-48 hours between collections, given
that no more than two months have elapsed since the
onset of paralysis [5]. Moreover, one stool sample is
collected from at least 3 contacts less than 15 years of
age who have been in direct contact with the index AFP
case within one week prior to the onset of paralysis
and/or within two weeks after onset. If the contact
numbers are inadequate, sampling from children in
the neighbourhood are collected. Following collection, the
specimens are kept in a cold box between frozen ice packs
at 4-8°C to be sent to the National Polio Laboratory in
Baghdad accompanied by a WHO-standardized form for
laboratory analysis.
At least 60 days after the onset of paralysis, all surviving
patients are re-examined by an Expert Committee
member for residual paralysis in the premise that such a
finding would provide further evidence that the cause of
paralysis is poliovirus.
Case definition of AFP
A “suspected polio” case is defined as “acute, flaccid
paralysis in a child aged <15 years including Guillain-Barre
syndrome; or any paralytic illness in a person of any age
when polio is suspected [5]”.
“Suspected polio” or AFP is a temporary diagnosis that
needs to be finally classified by an Expert Committee into
either: confirmed polio, polio-compatible, or discarded.
Such a classification is done on either clinical or virological
basis; the latter being used in Iraq since the year 2000 [5].
Surveillance performance indicators
The performance indicators were evaluated in comparison
to specific WHO recommended cut-off levels described in
the Results and Discussion section [5].
Results and discussion
Epidemiology of AFP
Given the heterogeneity of AFP etiology, each disease has
its own epidemiological characteristics. Nevertheless, these
characteristics are largely driven by GBS epidemiology as it
represents the vast majority of reported cases (see below).
A total of 4974 cases of AFP were reported from Iraq
between January 1997 and December 2011. Of those,
Table 1 Causes of AFP in Iraq, 1997-2011
Cause Number (%)
Guillain-Barré syndrome 2611 (52.5)
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2848 (57.3%) were males and 1990 (40%) were females.
The gender of the remaining 136 (2.7%) was unidentified
in the database. The age of reported cases ranged from
5 days to 14 years, with a mean of 3 years and median of
2.5 years. The annual incidence of AFP was calculated to
be 2.5/100,000 population from 1997-2011. Guillain-Barré
syndrome represented more than half of the reported
cases (N = 2611, 52.5%), followed by traumatic neuritis
(N = 715, 14.4%), and other CNS infections (5.9%) (Table 1).
Poliomyelitis accounted for 166 (3.3%) of cases, the
last reported case being in January 2000 (Figure 1).
Other conditions including brain tumors, intracranial
hemorrhage, electrolyte imbalance, epilepsy, hypokalemia,
and myopathy accounted for 622 (12.5%) of cases. The
exact cause of AFP was not identified in 568 (11.4%) of
reported cases. About 96% of cases were reported from
the public hospitals. All cases were of Iraqi nationality.
The greatest number of cases was reported from the
provinces of Baghdad, Ninewa, and Basrah (Figure 2).
Case-fatality rate of poliomyelitis was the highest
among all other causes of AFP (Figure 3).
AFP case classification
Wild polio virus was detected in 166 samples. In the re-
mainder, the stool specimens were adequate, and hence
sufficient to exclude poliomyelitis, in 4285 (86.1%) of
cases (Figure 4). Of the remaining 523 cases with in-
adequate stool specimens, paralytic poliomyelitis was
excluded by resolution of paralysis when followed
after 60 days of the onset of paralysis in 302 cases,
while the Expert Committee excluded poliomyelitis in
221 cases with residual paralysis, lost to follow-up, or
died before the expected follow-up date. One case of
those who died before the expected follow-up date
was labelled as “compatible” with poliomyelitis. The
case was reported in August 2000.
Impact of political and socio-economic changes on polio
eradication strategies in Iraq
Polio eradication strategies in Iraq witnessed dynamic
changes over the last two decades. Mandating routine
immunization against polio was followed by significant
increase in coverage rates in late 1980s [7]. However, fol-
lowing the 1990-1991 Gulf War and the subsequent eco-
nomic embargo, public health budget sustained a
serious decline by 90% [13]. Polio, like many other
vaccine-preventable diseases, was widely reported in
Iraq during early 1990s due to lack of vaccine supply, poor
maintenance of vaccine cold chain, and disrupted
infrastructure of the health care system in the country.
Following the Oil for Food Program adoption by the UN
Security Council in 1995, at least two polio vaccination
campaigns were held in Iraq every year with resultant
increase in coverage rates to those of pre-1990s era [14].
As an emergent response to the polio outbreak in
1999, Iraqi Ministry of Health with the assistance of
WHO and UNICEF, conducted two rounds of eminently
successful vaccinations of eligible population through
National Immunization Days (NIDs) in October and
November 1999 [5].
Following the 2003 war, more than 30% of primary
care clinics, 12% of hospitals and 15% of child care
clinics were looted or damaged. Likewise, the two
central public health laboratories were destroyed and the
Figure 1 Number of poliomyelitis cases per year, Iraq, 1997-2011.
Figure 2 Number of AFP cases reported per province,
Iraq, 1997-2011.
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Institute of Vaccine and Sera was stripped of equipment
and vaccine supply [14]. Immunization campaigns were
successfully re-launched by the Disaster Assistance
Response Team represented by UNICEF and WHO in
the second half of 2003. However, Polio vaccine efforts
were significantly hindered by shortage of vaccine
supply, failure of cold chain maintenance, and the lack
of security and sectarian violence in the Southern and
Central provinces [13-16]. On the other hand, the
semi-autonomous northern Kurdish provinces witnessed
significantly better primary health care services owing to
the political and economic stability in the region. Neonatal
polio vaccine coverage rate exceeded 70% in Kurdistan
Region by 2010 compared to an opposite trend to 40% in
the central and southern provinces [14].
A recent study has demonstrated that children exposed to
the war were over 20 percentage points less likely to be im-
munized compared with non-exposed ones, even after con-
trolling for such confounders as individual and household
characteristics, year of birth and province of residence [14].
Figure 3 Case fatality rate of selected causes of AFP, Iraq, 1997-2011.
Figure 4 Virological flowchart and case classification of the reported AFP cases, Iraq, 1997-2011.
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AFP surveillance evaluation
Evaluation of the AFP surveillance system is based on a
number of pre-set WHO indicators (Figure 5), including:
Sensitivity and positive predictive value
Sensitivity refers to “the proportion of cases of a disease
(or other health-related event) detected by the surveillance
system [17]”. The annual detection of at least one
non-poliomyelitis AFP case per 100,000 population under
the age of 15 years is the WHO’s recommended sensitivity
measure for the AFP surveillance system. There was a
notable increase in the reported annual rates of AFP in
Iraq from 1.1 cases/100,000 population under the age of
15 years in 1997 to 3.5 cases/100,000 population under
the age of 15 years in 2011. The national average rate from
1997-2011 was 2.5 AFP cases/100,000 population under
the age of 15 years.
However, a better way to estimate the actual incidence
of AFP in the population is to use the capture-recapture
method for the cases in which the national-registered cases
are compared to the hospital-registered ones as primary
and secondary case ascertainment sources, respectively
[18-20]. Obviously, this is a laborious method and difficult
to apply to the whole country as it is an exceptionally
hard task to evaluate all hospital records for AFP cases,
especially since Iraq does not currently have reliable
systems for retrospective patient data review [13,19,21].
The positive predictive value, defined as “the proportion
of reported cases that actually have the health-related
event under surveillance [17]”, is difficult to determine for
the AFP surveillance system in Iraq as the diagnosis is
strictly clinical and only the true AFP cases are virtually
registered in the local and national databases.
Completeness
Completeness of reports is an important quantitative
measure of the “acceptability” of public health surveillance
systems, the latter reflecting “the willingness of persons and
organizations to participate in the surveillance system [17]”.
The following completeness measures are recommended
for AFP surveillance:
– Completeness of reporting: Almost 96% of expected
routine (weekly or monthly) AFP surveillance
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Figure 5 AFP surveillance performance according to pre-selected WHO indicators, Iraq, 1997-2011.
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reports from all over Iraq were received on time,
including zero reports.
– Completeness of investigation: Clinical and
virological investigation was done for all AFP cases
having ‘adequate’ stool specimens collected.
– Completeness of follow-up: A follow-up examination
for residual paralysis was performed for 94% of AFP
cases at 60 days after the onset of paralysis.
Timeliness
Another quantitative measure of surveillance program
“acceptability”, timeliness refers to “the speed between
steps in a public health surveillance system [17]”. In
case of AFP surveillance, the following intervals are
measured:
– Timely notification: This refers to the interval
between the onset of paralysis and the notification
of the AFP Surveillance Team at the local
Directorate of Health, which is estimated to be
7 days. This is a crucial step to summon public
health effort needed to prevent further transmission
of infection. Unfortunately, this indicator is slightly
under the cut-off level of 80% in Iraq. This might
reflect either a delay in seeking treatment or delayed
notification by the caregiving physicians (Figure 6).
Figure 6 Map of Iraq depicting the percentage of AFP cases notified within 7 days from the onset of paralysis, Iraq, 1997-2011.
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– Timely investigation: Refers to the interval between
case notification and investigation by the designated
AFP Surveillance Team. It reflects the response
of the AFP Surveillance Team to health-related
emergencies. The vast majority of reported AFP
cases (91%) in Iraq were investigated within the
allocated 48-hour interval.
– Timeliness of stool collection: There was a steady
increase in the proportion of cases from which two
adequate stool specimens (>8 grams) were collected
with an interval of 24-48 hours between collections,
given that the onset of paralysis was within 2 months
of notification. This reflects better awareness of
patients’ families and medical caregivers to the
importance of early detection and technique of
stool collection.
– Timeliness of specimen receipt by the laboratory:
Unfortunately, stool cultures from only 63% of cases
were received by the National Poliovirus Laboratory
in Baghdad within 3 days of collection. Only 2 of
the 18 Iraqi provinces maintained a level above the
cut-off point of 80% (Figure 7). This is mainly due to
difficulty in inter-and-intra-provincial transportation,
which is largely attributed the challenging security
situation in the country.
– Timeliness of result reporting: Prompt analysis and
feedback from the National Poliovirus Laboratory in
Baghdad to the local and international health
authorities in cases of emergency is essential to cut the
chain of outbreak transmission. Results of virological
stool studies for 89% of cases were appropriately
reported within 28 days of receiving the cultures.
Figure 7 Map of Iraq depicting the percentage of stool Specimens received by the laboratory within 3 days of collection, Iraq,
1997-2011.
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Quality of laboratory performance
The Iraqi National Poliovirus Laboratory in Baghdad
is a WHO-accredited laboratory within the Eastern
Mediterranean Region (EMR) Poliovirus Laboratories
network [7]. The sensitivity of the laboratory to detect
poliomyelitis is reflected by its ability to detect non-
poliomyelitis enteroviruses (NPEV) in at least 10% of
cases, given that NPEVs have a worldwide distribution
and they are not targeted for eradication [22]. Besides
the timely processing of stool culture analysis and
reporting of results, the National Poliovirus Laboratory in
Baghdad was able to detect non-poliomyelitis NPEVs in
18% of cases.
Usefulness
The usefulness of a public health surveillance system
is indicated by its ability to fulfil its objectives related
to disease prevention, health promotion, and policy
decision-making [17]. Since its adoption in 1997, the
AFP surveillance system in Iraq has proven its efficacy in
detecting AFP cases and successfully met most of the
timeliness and completeness parameters of surveillance.
Via documentation of the causes of AFP in the country,
the AFP surveillance system resulted in the certification of
Iraq as polio-free. The AFP surveillance system provides
important estimates of morbidity and mortality related to
various causes of paralysis among Iraqi children and
stimulates research about potentially effective control
and policy-making measures.
Representativeness
The representativeness of a public health surveillance
system is reflected in its ability to document the time-trend
for disease occurrence and its geographic and demographic
distribution [17]. The AFP surveillance system in Iraq
covers the age groups below 15 in all of the 18 provinces in
the country, regardless of their gender, socioeconomic
status, and residence within or outside the capital city of the
province. The vast majority of the cases (96%) were reported
from public hospitals that provide universal health care over
all the country. However, there remains a chance of under-
reporting from the private clinics that can function remotely
from the direct supervision of public health authorities.
Cost-effectiveness
Since its adoption by WHO in 1988, the GPEI has
successfully prevented more than 8 million life-long
paralytic cases of poliomyelitis. In a recent study published
in November 2010 in Vaccine, Tebbens et al estimated the
cost benefits from the adoption of GPEI to be $ 40-50 bil-
lion from 2008-2035. Most of these benefits are attributed
to the prevention of the high hospitalization rates among
children with paralytic poliomyelitis and subsequent
disability prevention, improved productivity and reduced
costs of rehabilitation. Low-income countries receive
almost 85% of the estimated total net benefits, given the
huge number of paralytic poliomyelitis prevented in their
otherwise highly susceptible populations [23].
Conclusions
AFP surveillance remains the gold standard method of
poliomyelitis detection. This has increased people’s and
clinicians’ awareness of the importance to promptly
notify suspected cases and the timely transportation of
stool specimens to the National Poliovirus Laboratory in
Baghdad, or alternatively have more than one laboratory
for poliovirus detection in the country, all of which
are very useful measures to increase the surveillance
performance in the country. Capture-recapture method
can be used in order to get a more accurate estimate of
the incidence of AFP in at least some parts of the country.
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